Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-14

Clinical Trial Update: Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation [NA]

View source ↗

Summary

Clinical trial update for optimized posterior wall ablation in persistent atrial fibrillation; the study is currently recruiting at Shanghai Chest Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Persistent Atrial Fibrillation | NA | Status: RECRUITING